| Literature DB >> 31506513 |
Heeji Shin1, Ki Byung Song2, Young Il Kim1, Young-Joo Lee1, Dae Wook Hwang1, Jae Hoon Lee1, Sang Hyun Shin1, Jaewoo Kwon1, Shadi Alshammary1, Guisuk Park1, Yejong Park1, Seung Jae Lee1, Song Cheol Kim1.
Abstract
There is little evidence on the safety and benefits of laparoscopic pancreaticoduodenectomy (LPD) in elderly patients; therefore, we evaluated the feasibility and efficacy of this procedure by comparing perioperative and oncological outcomes between LPD and open pancreaticoduodenectomy (OPD) in elderly patients. We retrospectively reviewed the data of 1,693 patients who underwent PD to manage periampullary tumours at a single institution between January 2014 and June 2017. Of these patients, 326 were elderly patients aged ≥70 years, with 56 patients allocated to the LPD group and 270 to the OPD group. One-to-one propensity score matching (56:56) was used to match the baseline characteristics of patients who underwent LPD and OPD. LPD was associated with significantly fewer clinically significant postoperative pancreatic fistulas (7.1% vs. 21.4%), fewer analgesic injections (10 vs. 15.6 times; p = 0.022), and longer operative time (321.8 vs. 268.5 minutes; p = 0.001) than OPD in elderly patients. There were no significant differences in 3-year overall and disease-free survival rates between the LPD and OPD groups. LPD had acceptable perioperative and oncological outcomes compared with OPD in elderly patients. LPD is a reliable treatment option for elderly patients with periampullary tumours.Entities:
Mesh:
Year: 2019 PMID: 31506513 PMCID: PMC6737197 DOI: 10.1038/s41598-019-49455-9
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic data and perioperative and pathological outcomes in 326 elderly patients who underwent LPD and OPD.
| Variables | LPD (n = 56) | OPD (n = 270) | p-value |
|---|---|---|---|
| Age (years) ± SD | 74.8 ± 3.7 | 74.6 ± 3.5 | 0.703 |
| Sex (male:female) | 27:29 | 153:117 | 0.248 |
| Body mass index (kg/m2) ± SD | 22.8 ± 2.6 | 23.6 ± 2.9 |
|
| American Society of Anesthesiologists score ± SD | 2.1 ± 0.5 | 2.1 ± 0.4 | 0.987 |
| Preoperative biliary drainage, n (%) | 31 (55.4) | 198 (73.3) |
|
| Operative time (min) ± SD | 321.8 ± 56.1 | 288.6 ± 68.8 |
|
| Pathology, n (%) |
| ||
| Pancreatic cancer | 14 (25%) | 115 (42.6%) | |
| Distal common bile duct cancer | 19 (33.9%) | 92 (34.1%) | |
| Ampulla of Vater and duodenal cancer | 23 (41.1%) | 63 (23.3%) | |
| Postoperative hospital stay (days) ± SD | 13.5 ± 11.3 | 16.5 ± 11.3 | 0.12 |
Abbreviations: LPD, laparoscopic pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; SD, standard deviation.
In-hospital complications in 326 elderly patients who underwent LPD and OPD.
| Surgical complication according to Clavien–Dindo classification | LPD (n = 56) | OPD (n = 270) | |
|---|---|---|---|
| No complication | 36 | 102 | |
| Grade I | 10 | 63 | |
| Chylous ascites treated with low-long-chain triglyceride diet | 9 | 56 | |
| Superficial wound infection treated with bedside care | 1 | 7 | |
| Grade II | 7 | 72 | |
| Antibiotic therapy for intra-abdominal fluid collection | 4 | 46 | |
| Ileus | 9 | ||
| Delayed gastric emptying | 3 | ||
| Pneumonia | 3 | ||
| Atrial fibrillation | 4 | ||
| Pseudomembranous colitis | 3 | ||
| Postoperative pancreatitis | 1 | ||
| Uncontrolled ascites in patients with liver cirrhosis | 1 | 1 | |
| Bile leakage treated with conservative management | 1 | ||
| Postoperative delirium | 1 | ||
| Grade III | 0 | 24 | |
| Grade IIIa | 19 | ||
| Grade B pancreatic fistula with drainage | 14 | ||
| Pseudoaneurysmal bleeding treated with embolization | 1 | ||
| Bile leakage treated with interventional therapy | 2 | ||
| Pulmonary artery thromboembolism (inferior vena cava | |||
| filter insertion) | 1 | ||
| Delayed gastric emptying (duodenojejunostomy site stenosis treated with balloon dilatation) | 1 | ||
| Grade IIIb | 5 | ||
| Wound dehiscence | 4 | ||
| Mechanical ileus with adhesiolysis | 1 | ||
| Grade IV (intensive care unit treatment) | 3 | 6 | |
| Grade C pancreatic fistula (pancreaticojejunostomy revision) | 1 | 1 | |
| Intra-abdominal fluid collection with sepsis | 1 | ||
| Pseudoaneurysmal bleeding (stent graft insertion) | 1 | ||
| Pseudoaneurysmal bleeding (embolization) | 1 | ||
| Pneumonia with respiratory failure | 2 | ||
| Air embolism and heart failure | 1 | ||
| Atrial fibrillation | 1 | ||
| Grade V | 0 | 3 | |
| Aspiration pneumonia | 1 | ||
| Septic shock with gastric perforation due to ischemia | 1 | ||
| Postoperative bleeding with duodenojejunostomy disruption | 1 | ||
| Surgical complication according to Clavien–Dindo classification | 20 (35.7%) | 168 (62.2%) |
|
| Grade I | 10 | 63 | |
| Grade II | 7 | 72 | |
| Grade III | 0 | 24 | |
| Grade IV | 3 | 6 | |
| Grade V | 0 | 3 | |
| Major morbidity (≥Grade III) | 3 (5.4%) | 33 (12.2%) | 0.136 |
| Pancreatic fistula by ISGPS | |||
| Biochemical leakage | 12 (21.4%) | 87 (32.2%) | |
| Grade B | 3 (5.6%) | 61 (22.6%) | |
| Grade C | 1 (1.8%) | 1 (0.4%) | |
| Overall pancreatic fistula | 16 (28.6%) | 149 (55.2%) |
|
| Clinically significant pancreatic fistula | 4 (7.1%) | 62 (23%) |
|
Abbreviations: LPD, laparoscopic pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; ISGPS, International Study Group of Pancreatic Surgery.
Baseline parameters in the propensity score-matched groups.
| Variables | LPD (n = 56) | OPD (n = 56) | p-value |
|---|---|---|---|
| Age (years) ± SD | 74.8 ± 3.7 | 74.7 ± 3.5 | 0.99 |
| Sex (male:female) | 27:29 | 25:31 | 0.71 |
| Body mass index (kg/m2) ± SD | 22.8 ± 2.6 | 22.6 ± 2.3 | 0.75 |
| ASA score (mean) ± SD | 2.1 ± 0.5 | 2.1 ± 0.4 | 1 |
| Preoperative biliary drainage, n (%) | 31 (55.4) | 33 (58.9) | 0.85 |
| Pathology, n (%) | 1 | ||
| Pancreatic cancer | 14 (25) | 14 (25) | |
| Ampulla of Vater or duodenal cancer | 23 (41.1) | 23 (41.1) | |
| Distal common bile duct cancer | 19 (33.9) | 19 (33.9) |
Abbreviations: LPD, laparoscopic pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; BMI, body mass index; ASA, American Society of Anesthesiologists; SD, standard deviation.
Operative and perioperative outcomes.
| LPD (n = 56) | OPD (n = 56) | p-value | |
|---|---|---|---|
| Operative time (min) ± SD | 321.8 ± 56.1 | 268.5 ± 70.5 |
|
| Estimated blood loss (mL) ± SD | 468 ± 331 | 362 ± 363 | 0.11 |
| Soft diet starting time (postoperative day) ± SD | 5.6 ± 3 | 5.7 ± 6.3 | 0.94 |
| Postoperative hospital stay (day) ± SD | 13.5 ± 11.3 | 15.7 ± 12.7 | 0.323 |
| Number of analgesic injections, n ± SD | 9.6 ± 8.5 | 14.3 ± 13.1 |
|
| Surgical complication according to Clavien–Dindo classification | 20 (35.7%) | 32 (57.1%) |
|
| Grade I | 10 | 12 | |
| Grade II | 7 | 14 | |
| Grade III | 0 | 4 | |
| Grade IV | 3 | 2 | |
| Major morbidity | 3 (5.4%) | 6 (10.7%) | 0.297 |
| Readmission | 9 | 5 | 0.253 |
| Pancreatic fistula by ISGPS | |||
| Biochemical leakage | 12 (21.4%) | 23 (41.1%) | |
| Grade B | 3 (5.4%) | 12 (21.4%) | |
| Grade C | 1 (1.8%) | 0 | |
| Overall pancreatic fistula | 16 (28.6%) | 35 (62.5%) |
|
| Clinically significant pancreatic fistula | 4 (7.1%) | 12 (21.4%) |
|
Clavien–Dindo grade > III was defined as a major complication.
Pancreatic fistula was graded according to the modified 2016 ISGPS.
Clinical effect of biochemical leakage grades B/C indicated clinically significant pancreatic fistula.
Abbreviations: LPD, laparoscopic pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; ISGPS, International Study Group of Pancreatic Surgery; SD, standard deviation.
Comparison of oncological outcomes in elderly patients with periampullary tumours in the LPD and OPD groups.
| LPD (n = 49) | OPD (n = 50) | p-value | |
|---|---|---|---|
| Diagnosis | |||
| Pancreatic cancer | 8 | 10 | |
| Ampulla of Vater cancer | 18 | 18 | |
| Distal common bile duct cancer | 19 | 19 | |
| Duodenal cancer | 4 | 3 | |
| Age (years) ± SD | 74.9 ± 3.7 | 74.6 ± 3.5 | 0.703 |
| Sex (male:female) | 26:23 | 23:27 | 0.482 |
| Tumour size (cm) ± SD | 2.7 ± 1.2 | 2.6 ± 1.2 | 0.623 |
| Rate of positive LN, n (%) | 17 (34.7%) | 21 (42%) | 0.455 |
| Total number of LN, n ± SD | 15.3 ± 8.7 | 17.7 ± 8.3 | 0.152 |
| Surgical margin, n (%) | 0.443 | ||
| R0 | 44 (89.8) | 47 (94) | |
| R1 | 5 (10.2) | 3 (6) | |
| Perineural invasion, n (%) | 0.257 | ||
| Yes | 18 (36.7) | 24 (48) | |
| No | 31 (62.3) | 26 (52) | |
| Lymphovascular invasion, n (%) | 0.916 | ||
| Yes | 23 (46.9) | 24 (48) | |
| No | 26 (53.1) | 26 (52) | |
| Differentiation, n (%) | 0.413 | ||
| Well differentiated | 9 (18.4) | 11 (22) | |
| Moderately differentiated | 29 (59.2) | 27 (54) | |
| Poorly differentiated | 9 (18.4) | 6 (12) | |
| Unknown | 2 (4) | 6 (12) | |
| 3-year overall survival rate, (%) | 68.8 | 83.2 | 0.383 |
| 3-year disease-free survival rate, (%) | 53.3 | 65.6 | 0.71 |
Abbreviations: LPD, laparoscopic pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; SD, standard deviation; LN, lymph nodes; R0, negative resection margin; R1, positive resection margin.
Figure 1Comparison of Kaplan–Meier survival curve for (A) overall survival and (B) disease-free survival between open and laparoscopic pancreaticoduodenectomy.
Figure 2Flow chart of patient inclusion. The study enrolled 326 patients aged ≥70 years who underwent PD to manage periampullary tumours. The patients were divided into two operative groups for analysis: 56 patients in the LPD group and 270 in the OPD group. To control for selection bias, a comparative study was performed in 112 patients using one-to-one propensity-score matching (56 patients in the LPD group, 56 in the OPD group). Abbreviations: PD, pancreaticoduodenectomy; LPD, laparoscopic pancreaticoduodenectomy; OPD, open pancreaticoduodenectomy; BMI, body mass index; ASA, American Society of Anesthesiologists.